Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Cmpd10357 to treat B-cell acute lymphoblastic leukemia

Experimental Hematology(2023)10.1016/j.exphem.2022.12.005Source: DataRank Database

Cmpd10357 to treat B-cell acute lymphoblastic leukemia is a research paper published in Experimental Hematology (2023). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

Linked data & code

cellosaurus

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.19)OA: hybridTopics (96)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Hiroaki Konishi ORCID,Elizabeth Helmke ORCID,Masami Ijiri,Jan Michael A. Lerot,Emma Hicks

Live enrichment

PubMed:36621746 PMC:PMC10033359 OpenAlex:https://openalex.org/W4313547152

NIA NIH HHS

Grant: R21 AG065908

NINDS NIH HHS

Grant: U54 NS079202

National Institutes of Health

Grant: 1R21AG065908-01

Inhibiting AD Inflammation with a Novel Class of Small Molecule PAI-1 Antagonists

National Institutes of Health

Grant: 4U54NS079202-05

Novel anticonvulsant and neuroprotective therapies for TETS and OP intoxication

FWCI

0.19

Citation Percentile

0.4%

Citation Trend

2025

hybridLicense: cc-by

journalhttps://doi.org/10.1016/j.exphem.2022.12.005

publisherhttps://doi.org/10.1016/j.exphem.2022.12.005

publisherhttps://api.elsevier.com/content/article/PII:S0301472X22008402?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0301472X22008402?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36621746

Fields of Study

Cell death mechanisms and regulationAcute Lymphoblastic Leukemia researchCancer therapeutics and mechanisms0301 basic medicine0303 health sciences03 medical and health sciencesHumansMiceAnimalsChildApoptosisAntineoplastic AgentsCaspasesPrecursor B-Cell Lymphoblastic Leukemia-LymphomaBurkitt LymphomaCell Line, Tumor

MeSH Terms

AnimalsAntineoplastic AgentsBurkitt LymphomaChildHumansPrecursor B-Cell Lymphoblastic Leukemia-LymphomaApoptosisCaspasesCell Line, TumorMice

Keywords

CytotoxicityApoptosisCytotoxic T cellCancer researchLeukemiaMedicineCell cultureNecrosisProgrammed cell deathPharmacologyChemistryImmunologyInternal medicineBiologyIn vitroBiochemistryGeneticsWomen's Health (rcdc)Cardiorespiratory Medicine and HaematologyMiceChildhood Leukemia (rcdc)Animals (mesh)32 Biomedical and Clinical Sciences (for-2020)ChildCancerPediatricCancer (rcdc)Humans (mesh)TumorMice (mesh)3201 Cardiovascular medicine and haematology (for-2020)HematologyBurkitt LymphomaPediatric Cancer (rcdc)Antineoplastic Agents (mesh)5.1 PharmaceuticalsCaspasesApoptosis (mesh)Tumor (mesh)BiotechnologyImmunology (science-metrix)Childhood LeukemiaPediatric CancerPrecursor B-Cell Lymphoblastic Leukemia-Lymphoma (mesh)Oncology and CarcinogenesisChild (mesh)610Antineoplastic AgentsBiotechnology (rcdc)Cardiovascular medicine and haematologyArticleCell LineRare Diseases (rcdc)Caspases (mesh)Rare Diseases5.1 Pharmaceuticals (hrcs-rac)Burkitt Lymphoma (mesh)1102 Cardiorespiratory Medicine and Haematology (for)Precursor B-Cell Lymphoblastic Leukemia-LymphomaCell Line, TumorHumansAnimalsPediatric (rcdc)Hematology (rcdc)Biomedical and Clinical SciencesCancer (hrcs-hc)Orphan Drug3211 Oncology and Carcinogenesis (for-2020)Orphan Drug (rcdc)Women's Health

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Cmpd10357 to treat B-cell acute lymphoblastic leukemia

FAIR Checklist

Authors (9)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)